Cover Image
市場調查報告書

全球中風 (腦血管障礙) 管理市場

Global Stroke Management Market Analysis (2017-2023)

出版商 KBV Research 商品編碼 602223
出版日期 內容資訊 英文 253 Pages
訂單完成後即時交付
價格
Back to Top
全球中風 (腦血管障礙) 管理市場 Global Stroke Management Market Analysis (2017-2023)
出版日期: 2017年12月29日 內容資訊: 英文 253 Pages
簡介

本報告提供全球中風 (腦血管障礙) 管理市場相關調查分析,市場概要,各市場區隔的市場分析,各地區的市場分析,主要企業等系統性資訊。

第1章 調查範圍、手法

第2章 市場概要

  • 簡介
  • 促進因素、阻礙因素,機會

第3章 全球中風 (腦血管障礙) 管理市場

  • 各類型

第4章 全球中風 (腦血管障礙) 管理市場:各用途

  • 簡介

第5章 全球中風 (腦血管障礙) 管理市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第6章 企業簡介

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Teleflex Inc.
  • Cardinal Health
  • Medtronic Plc
  • General Electric (GE)
  • Merck Sharp & Dohme Corp.
  • ABBOTT
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb
目錄

The Global Stroke Management Market size is expected to reach $36.7 billion by 2023, rising at a market growth of 7.4% CAGR during the forecast period. Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth.

Based on Type, the market report segments the market into Diagnostics and Therapeutics. Diagnostics type includes Computed Tomography Scan (CT Scan), Echocardiography Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, and Other Diagnostics. Therapeutics includes Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive. Based on Application, the market report segments the market into Ischemic Stroke and Haemorrhagic Stroke Based on Regions, the Stroke Management market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the Stroke Management Market. Key companies profiled in the report include B. Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., Cardinal Health, Medtronic Plc., General Electric (GE), Merck Sharp & Dohme Corp., ABBOTT, GlaxoSmithKline plc, and Bristol-Myers Squibb.

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1. Market Definition
  • 1.2. Objectives
  • 1.3. Market Scope
  • 1.4. Segmentation
    • 1.4.1. Global Stroke Management Market, by Type
    • 1.4.2. Global Stroke Management Market, by Application
    • 1.4.3. Global Stroke Management Market, by Geography
  • 1.5. Methodology for the research

Chapter 2. Market Overview

  • 2.1. Introduction
  • 2.2. Drivers, Restraints and Opportunities
    • 2.2.1. Market Drivers
    • 2.2.2. Market Restraints

Chapter 3. Global Stroke Management Market

  • 3.1. Global Stroke Management Market by Type
    • 3.1.1. Global Diagnostics Market by Region
    • 3.1.2. Global Diagnostics Market by Type
      • 3.1.2.1. Global Computed Tomography Scan (CT Scan) Market by Region
      • 3.1.2.2. Global Echocardiography Market by Region
      • 3.1.2.3. Global Magnetic Resonance Imaging (MRI) Market by Region
      • 3.1.2.4. Global Carotid Ultrasound Market by Region
      • 3.1.2.5. Global Cerebral Angiography Market by Region
      • 3.1.2.6. Global Electrocardiography Market by Region
      • 3.1.2.7. Global Other Diagnostics Market by Region
    • 3.1.3. Global Therapeutics Market by Region
    • 3.1.4. Global Therapeutics Market by Type
      • 3.1.4.1. Global Tissue Plasminogen Activator Systems Market by Region
      • 3.1.4.2. Global Anticoagulant Market by Region
      • 3.1.4.3. Global Antiplatelet Market by Region
      • 3.1.4.4. Global Antihypertensive Market by Region

Chapter 4. Global Stroke Management Market by Application

  • 4.1. Introduction
    • 4.1.1. Global Stroke Management for Ischemic Stroke Market by Region
    • 4.1.2. Global Stroke Management for Haemorrhagic Stroke Market by Region

Chapter 5. Global Stroke Management Market by Region

  • 5.1. Introduction
  • 5.2. North America Stroke Management Market
    • 5.2.1. North America Stroke Management Market by Type
      • 5.2.1.1. North America Diagnostics Market by Country
      • 5.2.1.2. North America Diagnostics Market by Type
        • 5.2.1.2.1. North America Computed Tomography Scan (CT Scan) Market by Country
        • 5.2.1.2.2. North America Echocardiography Market by Country
        • 5.2.1.2.3. North America Magnetic Resonance Imaging (MRI) Market by Country
        • 5.2.1.2.4. North America Carotid Ultrasound Market by Country
        • 5.2.1.2.5. North America Cerebral Angiography Market by Country
        • 5.2.1.2.6. North America Electrocardiography Market by Country
        • 5.2.1.2.7. North America Other Diagnostics Market by Country
      • 5.2.1.3. North America Therapeutics Market by Country
      • 5.2.1.4. North America Therapeutics Market by Type
        • 5.2.1.4.1. North America Tissue Plasminogen Activator Systems Market by Country
        • 5.2.1.4.2. North America Anticoagulant Market by Country
        • 5.2.1.4.3. North America Antiplatelet Market by Country
        • 5.2.1.4.4. North America Antihypertensive Market by Country
    • 5.2.2. North America Stroke Management Market by Application
      • 5.2.2.1. North America Stroke Management for Ischemic Stroke Market by Country
      • 5.2.2.2. North America Stroke Management for Haemorrhagic Stroke Market by Country
    • 5.2.3. North America Stroke Management Market by Country
      • 5.2.3.1. US Stroke Management Market
        • 5.2.3.1.1. US Stroke Management Market by Type
        • 5.2.3.1.2. US Stroke Management Market by Application
      • 5.2.3.2. Canada Stroke Management Market
        • 5.2.3.2.1. Canada Stroke Management Market by Type
        • 5.2.3.2.2. Canada Stroke Management Market by Application
      • 5.2.3.3. Mexico Stroke Management Market
        • 5.2.3.3.1. Mexico Stroke Management Market by Type
        • 5.2.3.3.2. Mexico Stroke Management Market by Application
      • 5.2.3.4. Rest of North America Stroke Management Market
        • 5.2.3.4.1. Rest of North America Stroke Management Market by Type
        • 5.2.3.4.2. Rest of North America Stroke Management Market by Application
  • 5.3. Europe Stroke Management Market
    • 5.3.1. Europe Stroke Management Market by Type
      • 5.3.1.1. Europe Diagnostics Market by Country
      • 5.3.1.2. Europe Diagnostics Market by Type
        • 5.3.1.2.1. Europe Computed Tomography Scan (CT Scan) Market by Country
        • 5.3.1.2.2. Europe Echocardiography Market by Country
        • 5.3.1.2.3. Europe Magnetic Resonance Imaging (MRI) Market by Country
        • 5.3.1.2.4. Europe Carotid Ultrasound Market by Country
        • 5.3.1.2.5. Europe Cerebral Angiography Market by Country
        • 5.3.1.2.6. Europe Electrocardiography Market by Country
        • 5.3.1.2.7. Europe Other Diagnostics Market by Country
      • 5.3.1.3. Europe Therapeutics Market by Country
      • 5.3.1.4. Europe Therapeutics Market by Type
        • 5.3.1.4.1. Europe Tissue Plasminogen Activator Systems Market by Country
        • 5.3.1.4.2. Europe Anticoagulant Market by Country
        • 5.3.1.4.3. Europe Antiplatelet Market by Country
        • 5.3.1.4.4. Europe Antihypertensive Market by Country
    • 5.3.2. Europe Stroke Management Market by Application
      • 5.3.2.1. Europe Stroke Management for Ischemic Stroke Market by Country
      • 5.3.2.2. Europe Stroke Management for Haemorrhagic Stroke Market by Country
    • 5.3.3. Europe Stroke Management Market by Country
      • 5.3.3.1. Germany Stroke Management Market
        • 5.3.3.1.1. Germany Stroke Management Market by Type
        • 5.3.3.1.2. Germany Stroke Management Market by Application
      • 5.3.3.2. UK Stroke Management Market
        • 5.3.3.2.1. UK Stroke Management Market by Type
        • 5.3.3.2.2. UK Stroke Management Market by Application
      • 5.3.3.3. France Stroke Management Market
        • 5.3.3.3.1. France Stroke Management Market by Type
        • 5.3.3.3.2. France Stroke Management Market by Application
      • 5.3.3.4. Russia Stroke Management Market
        • 5.3.3.4.1. Russia Stroke Management Market by Type
        • 5.3.3.4.2. Russia Stroke Management Market by Application
      • 5.3.3.5. Spain Stroke Management Market
        • 5.3.3.5.1. Spain Stroke Management Market by Type
        • 5.3.3.5.2. Spain Stroke Management Market by Application
      • 5.3.3.6. Italy Stroke Management Market
        • 5.3.3.6.1. Italy Stroke Management Market by Type
        • 5.3.3.6.2. Italy Stroke Management Market by Application
      • 5.3.3.7. Rest of Europe Stroke Management Market
        • 5.3.3.7.1. Rest of Europe Stroke Management Market by Type
        • 5.3.3.7.2. Rest of Europe Stroke Management Market by Application
  • 5.4. Asia Pacific Stroke Management Market
    • 5.4.1. Asia Pacific Stroke Management Market by Type
      • 5.4.1.1. Asia Pacific Diagnostics Market by Country
      • 5.4.1.2. Asia Pacific Diagnostics Market by Type
        • 5.4.1.2.1. Asia Pacific Computed Tomography Scan (CT Scan) Market by Country
        • 5.4.1.2.2. Asia Pacific Echocardiography Market by Country
        • 5.4.1.2.3. Asia Pacific Magnetic Resonance Imaging (MRI) Market by Country
        • 5.4.1.2.4. Asia Pacific Carotid Ultrasound Market by Country
        • 5.4.1.2.5. Asia Pacific Cerebral Angiography Market by Country
        • 5.4.1.2.6. Asia Pacific Electrocardiography Market by Country
        • 5.4.1.2.7. Asia Pacific Other Diagnostics Market by Country
      • 5.4.1.3. Asia Pacific Therapeutics Market by Country
      • 5.4.1.4. Asia Pacific Therapeutics Market by Type
        • 5.4.1.4.1. Asia Pacific Tissue Plasminogen Activator Systems Market by Country
        • 5.4.1.4.2. Asia Pacific Anticoagulant Market by Country
        • 5.4.1.4.3. Asia Pacific Antiplatelet Market by Country
        • 5.4.1.4.4. Asia Pacific Antihypertensive Market by Country
    • 5.4.2. Asia Pacific Stroke Management Market by Application
      • 5.4.2.1. Asia Pacific Stroke Management for Ischemic Stroke Market by Country
      • 5.4.2.2. Asia Pacific Stroke Management for Haemorrhagic Stroke Market by Country
    • 5.4.3. Asia Pacific Stroke Management Market by Country
      • 5.4.3.1. China Stroke Management Market
        • 5.4.3.1.1. China Stroke Management Market by Type
        • 5.4.3.1.2. China Stroke Management Market by Application
      • 5.4.3.2. Japan Stroke Management Market
        • 5.4.3.2.1. Japan Stroke Management Market by Type
        • 5.4.3.2.2. Japan Stroke Management Market by Application
      • 5.4.3.3. India Stroke Management Market
        • 5.4.3.3.1. India Stroke Management Market by Type
        • 5.4.3.3.2. India Stroke Management Market by Application
      • 5.4.3.4. South Korea Stroke Management Market
        • 5.4.3.4.1. South Korea Stroke Management Market by Type
        • 5.4.3.4.2. South Korea Stroke Management Market by Application
      • 5.4.3.5. Singapore Stroke Management Market
        • 5.4.3.5.1. Singapore Stroke Management Market by Type
        • 5.4.3.5.2. Singapore Stroke Management Market by Application
      • 5.4.3.6. Malaysia Stroke Management Market
        • 5.4.3.6.1. Malaysia Stroke Management Market by Type
        • 5.4.3.6.2. Malaysia Stroke Management Market by Application
      • 5.4.3.7. Rest of Asia Pacific Stroke Management Market
        • 5.4.3.7.1. Rest of Asia Pacific Stroke Management Market by Type
        • 5.4.3.7.2. Rest of Asia Pacific Stroke Management Market by Application
  • 5.5. LAMEA Stroke Management Market
    • 5.5.1. LAMEA Stroke Management Market by Type
      • 5.5.1.1. LAMEA Diagnostics Market by Country
      • 5.5.1.2. LAMEA Diagnostics Market by Type
        • 5.5.1.2.1. LAMEA Computed Tomography Scan (CT Scan) Market by Country
        • 5.5.1.2.2. LAMEA Echocardiography Market by Country
        • 5.5.1.2.3. LAMEA Magnetic Resonance Imaging (MRI) Market by Country
        • 5.5.1.2.4. LAMEA Carotid Ultrasound Market by Country
        • 5.5.1.2.5. LAMEA Cerebral Angiography Market by Country
        • 5.5.1.2.6. LAMEA Electrocardiography Market by Country
        • 5.5.1.2.7. LAMEA Other Diagnostics Market by Country
      • 5.5.1.3. LAMEA Therapeutics Market by Country
      • 5.5.1.4. LAMEA Therapeutics Market by Type
        • 5.5.1.4.1. LAMEA Tissue Plasminogen Activator Systems Market by Country
        • 5.5.1.4.2. LAMEA Anticoagulant Market by Country
        • 5.5.1.4.3. LAMEA Antiplatelet Market by Country
        • 5.5.1.4.4. LAMEA Antihypertensive Market by Country
    • 5.5.2. LAMEA Stroke Management Market by Application
      • 5.5.2.1. LAMEA Stroke Management for Ischemic Stroke Market by Country
      • 5.5.2.2. LAMEA Stroke Management for Haemorrhagic Stroke Market by Country
    • 5.5.3. LAMEA Stroke Management Market by Country
      • 5.5.3.1. Brazil Stroke Management Market
        • 5.5.3.1.1. Brazil Stroke Management Market by Type
        • 5.5.3.1.2. Brazil Stroke Management Market by Application
      • 5.5.3.2. Argentina Stroke Management Market
        • 5.5.3.2.1. Argentina Stroke Management Market by Type
        • 5.5.3.2.2. Argentina Stroke Management Market by Application
      • 5.5.3.3. UAE Stroke Management Market
        • 5.5.3.3.1. UAE Stroke Management Market by Type
        • 5.5.3.3.2. UAE Stroke Management Market by Application
      • 5.5.3.4. Saudi Arabia Stroke Management Market
        • 5.5.3.4.1. Saudi Arabia Stroke Management Market by Type
        • 5.5.3.4.2. Saudi Arabia Stroke Management Market by Application
      • 5.5.3.5. South Africa Stroke Management Market
        • 5.5.3.5.1. South Africa Stroke Management Market by Type
        • 5.5.3.5.2. South Africa Stroke Management Market by Application
      • 5.5.3.6. Nigeria Stroke Management Market
        • 5.5.3.6.1. Nigeria Stroke Management Market by Type
        • 5.5.3.6.2. Nigeria Stroke Management Market by Application
      • 5.5.3.7. Rest of LAMEA Stroke Management Market
        • 5.5.3.7.1. Rest of LAMEA Stroke Management Market by Type
        • 5.5.3.7.2. Rest of LAMEA Stroke Management Market by Application

Chapter 6. Company Profiles

  • 6.1. B. Braun Melsungen AG.
    • 6.1.1. Company Overview
    • 6.1.2. Financial Analysis
    • 6.1.3. Segmental Analysis
    • 6.1.4. Research & Development Expense
  • 6.2. Boston Scientific Corporation
    • 6.2.1. Company Overview
    • 6.2.2. Financial Analysis
    • 6.2.3. Segmental and Regional Analysis
    • 6.2.4. Research & Development Expense
  • 6.3. Teleflex Inc.
    • 6.3.1. Company Overview
    • 6.3.2. Financial Analysis
    • 6.3.3. Segmental Analysis
    • 6.3.4. Research & Development Expense
  • 6.4. Cardinal Health
    • 6.4.1. Company Overview
    • 6.4.2. Financial Analysis
    • 6.4.3. Segmental Analysis
  • 6.5. Medtronic Plc.
    • 6.5.1. Company Overview
    • 6.5.2. Financial Analysis
    • 6.5.3. Segmental and Regional Analysis
    • 6.5.4. Research & Development Expense
  • 6.6. General Electric (GE)
    • 6.6.1. Company Overview
    • 6.6.2. Financial Analysis
    • 6.6.3. Segmental and Regional Analysis
    • 6.6.4. Research & Development Expense
  • 6.7. Merck Sharp & Dohme Corp.
    • 6.7.1. Company Overview
    • 6.7.2. Financial Analysis
    • 6.7.3. Segmental and Regional Analysis
    • 6.7.4. Research & Development Expense
  • 6.8. ABBOTT
    • 6.8.1. Company Overview
    • 6.8.2. Financial Analysis
    • 6.8.3. Regional Analysis
    • 6.8.4. Research & Development Expense
  • 6.9. GlaxoSmithKline plc
    • 6.9.1. Financial Analysis
    • 6.9.2. Segmental and Regional Analysis
    • 6.9.3. Research & Development Expense

6.10. Bristol-Myers Squibb

    • 6.10.1. Company Overview
    • 6.10.2. Financial Analysis
    • 6.10.3. Regional Analysis
    • 6.10.4. Research & Development Expense

LIST OF TABLES

  • TABLE 1: GLOBAL STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 2: GLOBAL STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 3: GLOBAL STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 4: GLOBAL STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 5: GLOBAL DIAGNOSTICS MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 6: GLOBAL DIAGNOSTICS MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 7: GLOBAL DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 8: GLOBAL DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 9: GLOBAL COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 10: GLOBAL COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 11: GLOBAL ECHOCARDIOGRAPHY MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 12: GLOBAL ECHOCARDIOGRAPHY MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 13: GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 14: GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 15: GLOBAL CAROTID ULTRASOUND MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 16: GLOBAL CAROTID ULTRASOUND MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 17: GLOBAL CEREBRAL ANGIOGRAPHY MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 18: GLOBAL CEREBRAL ANGIOGRAPHY MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 19: GLOBAL ELECTROCARDIOGRAPHY MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 20: GLOBAL ELECTROCARDIOGRAPHY MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 21: GLOBAL OTHER DIAGNOSTICS MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 22: GLOBAL OTHER DIAGNOSTICS MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 23: GLOBAL THERAPEUTICS MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 24: GLOBAL THERAPEUTICS MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 25: GLOBAL THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 26: GLOBAL THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 27: GLOBAL TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 28: GLOBAL TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 29: GLOBAL ANTICOAGULANT MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 30: GLOBAL ANTICOAGULANT MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 31: GLOBAL ANTIPLATELET MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 32: GLOBAL ANTIPLATELET MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 33: GLOBAL ANTIHYPERTENSIVE MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 34: GLOBAL ANTIHYPERTENSIVE MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 35: GLOBAL STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 36: GLOBAL STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 37: GLOBAL STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 38: GLOBAL STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 39: GLOBAL STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 40: GLOBAL STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 41: GLOBAL STROKE MANAGEMENT MARKET BY REGION, 2013 - 2016, USD MILLION
  • TABLE 42: GLOBAL STROKE MANAGEMENT MARKET BY REGION, 2017 - 2023, USD MILLION
  • TABLE 43: NORTH AMERICA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 44: NORTH AMERICA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 45: NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 46: NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 47: NORTH AMERICA DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 48: NORTH AMERICA DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 49: NORTH AMERICA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 50: NORTH AMERICA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 51: NORTH AMERICA COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 52: NORTH AMERICA COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 53: NORTH AMERICA ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 54: NORTH AMERICA ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 55: NORTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 56: NORTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 57: NORTH AMERICA CAROTID ULTRASOUND MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 58: NORTH AMERICA CAROTID ULTRASOUND MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 59: NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 60: NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 61: NORTH AMERICA ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 62: NORTH AMERICA ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 63: NORTH AMERICA OTHER DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 64: NORTH AMERICA OTHER DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 65: NORTH AMERICA THERAPEUTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 66: NORTH AMERICA THERAPEUTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 67: NORTH AMERICA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 68: NORTH AMERICA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 69: NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 70: NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 71: NORTH AMERICA ANTICOAGULANT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 72: NORTH AMERICA ANTICOAGULANT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 73: NORTH AMERICA ANTIPLATELET MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 74: NORTH AMERICA ANTIPLATELET MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 75: NORTH AMERICA ANTIHYPERTENSIVE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 76: NORTH AMERICA ANTIHYPERTENSIVE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 77: NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 78: NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 79: NORTH AMERICA STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 80: NORTH AMERICA STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 81: NORTH AMERICA STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 82: NORTH AMERICA STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 83: NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 84: NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 85: US STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 86: US STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 87: US STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 88: US STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 89: US DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 90: US DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 91: US THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 92: US THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 93: US STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 94: US STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 95: CANADA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 96: CANADA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 97: CANADA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 98: CANADA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 99: CANADA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 100: CANADA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 101: CANADA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 102: CANADA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 103: CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 104: CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 105: MEXICO STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 106: MEXICO STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 107: MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 108: MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 109: MEXICO DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 110: MEXICO DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 111: MEXICO THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 112: MEXICO THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 113: MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 114: MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 115: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 116: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 117: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 118: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 119: REST OF NORTH AMERICA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 120: REST OF NORTH AMERICA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 121: REST OF NORTH AMERICA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 122: REST OF NORTH AMERICA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 123: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 124: REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 125: EUROPE STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 126: EUROPE STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 127: EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 128: EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 129: EUROPE DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 130: EUROPE DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 131: EUROPE DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 132: EUROPE DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 133: EUROPE COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 134: EUROPE COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 135: EUROPE ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 136: EUROPE ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 137: EUROPE MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 138: EUROPE MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 139: EUROPE CAROTID ULTRASOUND MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 140: EUROPE CAROTID ULTRASOUND MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 141: EUROPE CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 142: EUROPE CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 143: EUROPE ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 144: EUROPE ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 145: EUROPE OTHER DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 146: EUROPE OTHER DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 147: EUROPE THERAPEUTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 148: EUROPE THERAPEUTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 149: EUROPE THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 150: EUROPE THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 151: EUROPE TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 152: EUROPE TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 153: EUROPE ANTICOAGULANT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 154: EUROPE ANTICOAGULANT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 155: EUROPE ANTIPLATELET MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 156: EUROPE ANTIPLATELET MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 157: EUROPE ANTIHYPERTENSIVE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 158: EUROPE ANTIHYPERTENSIVE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 159: EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 160: EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 161: EUROPE STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 162: EUROPE STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 163: EUROPE STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 164: EUROPE STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 165: EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 166: EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 167: GERMANY STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 168: GERMANY STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 169: GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 170: GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 171: GERMANY DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 172: GERMANY DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 173: GERMANY THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 174: GERMANY THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 175: GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 176: GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 177: UK STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 178: UK STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 179: UK STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 180: UK STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 181: UK DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 182: UK DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 183: UK THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 184: UK THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 185: UK STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 186: UK STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 187: FRANCE STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 188: FRANCE STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 189: FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 190: FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 191: FRANCE DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 192: FRANCE DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 193: FRANCE THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 194: FRANCE THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 195: FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 196: FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 197: RUSSIA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 198: RUSSIA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 199: RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 200: RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 201: RUSSIA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 202: RUSSIA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 203: RUSSIA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 204: RUSSIA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 205: RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 206: RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 207: SPAIN STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 208: SPAIN STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 209: SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 210: SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 211: SPAIN DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 212: SPAIN DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 213: SPAIN THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 214: SPAIN THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 215: SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 216: SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 217: ITALY STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 218: ITALY STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 219: ITALY STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 220: ITALY STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 221: ITALY DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 222: ITALY DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 223: ITALY THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 224: ITALY THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 225: ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 226: ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 227: REST OF EUROPE STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 228: REST OF EUROPE STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 229: REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 230: REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 231: REST OF EUROPE DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 232: REST OF EUROPE DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 233: REST OF EUROPE THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 234: REST OF EUROPE THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 235: REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 236: REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 237: ASIA PACIFIC STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 238: ASIA PACIFIC STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 239: ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 240: ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 241: ASIA PACIFIC DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 242: ASIA PACIFIC DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 243: ASIA PACIFIC DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 244: ASIA PACIFIC DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 245: ASIA PACIFIC COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 246: ASIA PACIFIC COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 247: ASIA PACIFIC ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 248: ASIA PACIFIC ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 249: ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 250: ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 251: ASIA PACIFIC CAROTID ULTRASOUND MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 252: ASIA PACIFIC CAROTID ULTRASOUND MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 253: ASIA PACIFIC CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 254: ASIA PACIFIC CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 255: ASIA PACIFIC ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 256: ASIA PACIFIC ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 257: ASIA PACIFIC OTHER DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 258: ASIA PACIFIC OTHER DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 259: ASIA PACIFIC THERAPEUTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 260: ASIA PACIFIC THERAPEUTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 261: ASIA PACIFIC THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 262: ASIA PACIFIC THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 263: ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 264: ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 265: ASIA PACIFIC ANTICOAGULANT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 266: ASIA PACIFIC ANTICOAGULANT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 267: ASIA PACIFIC ANTIPLATELET MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 268: ASIA PACIFIC ANTIPLATELET MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 269: ASIA PACIFIC ANTIHYPERTENSIVE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 270: ASIA PACIFIC ANTIHYPERTENSIVE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 271: ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 272: ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 273: ASIA PACIFIC STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 274: ASIA PACIFIC STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 275: ASIA PACIFIC STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 276: ASIA PACIFIC STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 277: ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 278: ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 279: CHINA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 280: CHINA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 281: CHINA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 282: CHINA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 283: CHINA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 284: CHINA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 285: CHINA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 286: CHINA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 287: CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 288: CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 289: JAPAN STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 290: JAPAN STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 291: JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 292: JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 293: JAPAN DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 294: JAPAN DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 295: JAPAN THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 296: JAPAN THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 297: JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 298: JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 299: INDIA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 300: INDIA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 301: INDIA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 302: INDIA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 303: INDIA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 304: INDIA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 305: INDIA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 306: INDIA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 307: INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 308: INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 309: SOUTH KOREA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 310: SOUTH KOREA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 311: SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 312: SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 313: SOUTH KOREA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 314: SOUTH KOREA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 315: SOUTH KOREA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 316: SOUTH KOREA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 317: SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 318: SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 319: SINGAPORE STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 320: SINGAPORE STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 321: SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 322: SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 323: SINGAPORE DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 324: SINGAPORE DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 325: SINGAPORE THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 326: SINGAPORE THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 327: SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 328: SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 329: MALAYSIA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 330: MALAYSIA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 331: MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 332: MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 333: MALAYSIA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 334: MALAYSIA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 335: MALAYSIA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 336: MALAYSIA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 337: MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 338: MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 339: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 340: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 341: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 342: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 343: REST OF ASIA PACIFIC DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 344: REST OF ASIA PACIFIC DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 345: REST OF ASIA PACIFIC THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 346: REST OF ASIA PACIFIC THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 347: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 348: REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 349: LAMEA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 350: LAMEA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 351: LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 352: LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 353: LAMEA DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 354: LAMEA DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 355: LAMEA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 356: LAMEA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 357: LAMEA COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 358: LAMEA COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 359: LAMEA ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 360: LAMEA ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 361: LAMEA MAGNETIC RESONANCE IMAGING (MRI)MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 362: LAMEA MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 363: LAMEA CAROTID ULTRASOUND MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 364: LAMEA CAROTID ULTRASOUND MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 365: LAMEA CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 366: LAMEA CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 367: LAMEA ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 368: LAMEA ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 369: LAMEA OTHER DIAGNOSTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 370: LAMEA OTHER DIAGNOSTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 371: LAMEA THERAPEUTICS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 372: LAMEA THERAPEUTICS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 373: LAMEA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 374: LAMEA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 375: LAMEA TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 376: LAMEA TISSUE PLASMINOGEN ACTIVATOR SYSTEMS MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 377: LAMEA ANTICOAGULANT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 378: LAMEA ANTICOAGULANT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 379: LAMEA ANTIPLATELET MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 380: LAMEA ANTIPLATELET MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 381: LAMEA ANTIHYPERTENSIVE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 382: LAMEA ANTIHYPERTENSIVE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 383: LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 384: LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 385: LAMEA STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 386: LAMEA STROKE MANAGEMENT FOR ISCHEMIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 387: LAMEA STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 388: LAMEA STROKE MANAGEMENT FOR HAEMORRHAGIC STROKE MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 389: LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2013 - 2016, USD MILLION
  • TABLE 390: LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2017 - 2023, USD MILLION
  • TABLE 391: BRAZIL STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 392: BRAZIL STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 393: BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 394: BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 395: BRAZIL DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 396: BRAZIL DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 397: BRAZIL THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 398: BRAZIL THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 399: BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 400: BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 401: ARGENTINA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 402: ARGENTINA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 403: ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 404: ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 405: ARGENTINA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 406: ARGENTINA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 407: ARGENTINA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 408: ARGENTINA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 409: ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 410: ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 411: UAE STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 412: UAE STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 413: UAE STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 414: UAE STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 415: UAE DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 416: UAE DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 417: UAE THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 418: UAE THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 419: UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 420: UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 421: SAUDI ARABIA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 422: SAUDI ARABIA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 423: SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 424: SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 425: SAUDI ARABIA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 426: SAUDI ARABIA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 427: SAUDI ARABIA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 428: SAUDI ARABIA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 429: SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 430: SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 431: SOUTH AFRICA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 432: SOUTH AFRICA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 433: SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 434: SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 435: SOUTH AFRICA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 436: SOUTH AFRICA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 437: SOUTH AFRICA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 438: SOUTH AFRICA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 439: SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 440: SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 441: NIGERIA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 442: NIGERIA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 443: NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 444: NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 445: NIGERIA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 446: NIGERIA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 447: NIGERIA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 448: NIGERIA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 449: NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 450: NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 451: REST OF LAMEA STROKE MANAGEMENT MARKET, 2013 - 2016, USD MILLION
  • TABLE 452: REST OF LAMEA STROKE MANAGEMENT MARKET, 2017 - 2023, USD MILLION
  • TABLE 453: REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 454: REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 455: REST OF LAMEA DIAGNOSTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 456: REST OF LAMEA DIAGNOSTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 457: REST OF LAMEA THERAPEUTICS MARKET BY TYPE, 2013 - 2016, USD MILLION
  • TABLE 458: REST OF LAMEA THERAPEUTICS MARKET BY TYPE, 2017 - 2023, USD MILLION
  • TABLE 459: REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2013 - 2016, USD MILLION
  • TABLE 460: REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2017 - 2023, USD MILLION
  • TABLE 461: KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 462: KEY INFORMATION - BOSTON SCIENTFIC CORPORATION
  • TABLE 463: KEY INFORMATION -TELEFLEX INC.
  • TABLE 464: KEY INFORMATION - CARDINAL HEALTH
  • TABLE 465: BUSINESS SEGMENT - CARDINAL HEALTH
  • TABLE 466: KEY INFORMATION - MEDTRONIC PLC
  • TABLE 467: BUSINESS SEGMENT - MEDTRONIC
  • TABLE 468: KEY INFORMATION - GENERAL ELECTRIC (GE)
  • TABLE 469: KEY INFORMATION - MERCK SHARP & DOHME CORP.
  • TABLE 470: KEY INFORMATION - ABBOTT
  • TABLE 471: KEY INFORMATION - GLAXOSMITHKLINE PLC
  • TABLE 472: KEY INFORMATION - BRISTOL-MYERS SQUIBB
Back to Top